Abbvie Inc
NYSE:ABBV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abbvie Inc
NYSE:ABBV
|
US |
|
M
|
MSCI Inc
F:3HM
|
US |
|
Entra ASA
F:2EN
|
NO |
|
R
|
Realord Group Holdings Ltd
SWB:CUV
|
HK |
|
Lamar Advertising Co
NASDAQ:LAMR
|
US |
|
P
|
Persimmon PLC
XMUN:OHP
|
UK |
Wall St Price Targets
ABBV Price Targets Summary
Abbvie Inc
According to Wall Street analysts, the average 1-year price target for ABBV is 260.58 USD with a low forecast of 198.74 USD and a high forecast of 344.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABBV's stock price target?
Price Target
260.58
USD
According to Wall Street analysts, the average 1-year price target for ABBV is 260.58 USD with a low forecast of 198.74 USD and a high forecast of 344.4 USD.
What is the Revenue forecast for Abbvie Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Abbvie Inc?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for Abbvie Inc?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 12%.
What is the Pre-Tax Income forecast for Abbvie Inc?
Projected CAGR
81%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 81%.
What is the Net Income forecast for Abbvie Inc?
Projected CAGR
31%
Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is 31%.
